Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Provention Bio Inc (PRVB)

Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Provention Bio Inc 55 Broad Street 2nd Floor Red Bank NJ 07701 USA

www.proventionbio.com P: 908-336-0360

Description:

Provention Bio, Inc. is a biopharmaceutical company. It focuses on development of novel therapeutics and solutions to intercept and prevent immune-mediated disease. The company's product pipeline consists of PRV-031, PRV-6527, PRV-300, PRV-3279 and PRV-101 which are in clinical stage. Provention Bio, Inc. is based in NJ, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,367,629
Enterprise Value, $K 2,226,099
Shares Outstanding, K 94,781
Annual Sales, $ 12,900 K
Annual Net Income, $ -113,570 K
Last Quarter Sales, $ 10,810 K
Last Quarter Net Income, $ -33,280 K
60-Month Beta 2.47
% of Insider Shareholders 13.10%
% of Institutional Shareholders 37.39%
Float, K 82,365
% Float 86.90%
Short Volume Ratio 0.44

Growth:

1-Year Return 396.62%
3-Year Return 133.02%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.38 on 03/29/23
Latest Earnings Date 05/04/23
Earnings Per Share ttm -1.53
EPS Growth vs. Prev Qtr -11.76%
EPS Growth vs. Prev Year 7.32%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PRVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -103.36%
Return-on-Assets % -69.08%
Profit Margin % -880.39%
Debt/Equity 0.19
Price/Sales 178.10
Price/Cash Flow N/A
Price/Book 17.88
Book Value/Share 1.40
Interest Coverage -121.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar